Literature DB >> 23551774

PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors.

Ashish Malladi1, Maya Viner, Tatianie Jackson, Gustavo Mercier, Rathan M Subramaniam.   

Abstract

INTRODUCTION: To establish the effects of biological and procedural factors on mediastinal and liver [(18) F]-fluorodeoxyglucose (FDG) uptake in oncological FDG positron emission tomography/computed tomography (PET/CT).
METHODS: This retrospective study included 557 patients who had a baseline FDG PET/CT scan in 2008 and 2009. Mediastinal and liver standardised uptake values mean normalised to lean body mass (SUVlbm mean) were measured in each patient. Univariate and multivariate regression models were established. Study population was then dichotomised into low and high body mass index (BMI) groups, and linear regression models were established for the effects of age, incubation period and blood glucose levels.
RESULTS: BMI had the highest adjusted effect (standardised beta coefficient, b = 0.43) (P < 0.001) and partial correlation, adjusting for covariates included in the final model (r = 0.45; P < 0.001) on mediastinal FDG uptake. Partial correlations (r) were 0.22 for age, -0.17 for male gender, -0.25 for incubation period and 0.14 for blood glucose (P < 0.001). The linear regression models showed significant differences in mediastinal FDG uptake between the low and high BMI groups and the effects of age, incubation period and basal blood glucose levels (P < 0.001). Similar results were observed for liver FDG uptake except the partial correlation for incubation period was r = -0.09 (P = 0.02).
CONCLUSION: BMI has the highest effect and correlation on mediastinal and liver FDG uptake. FDG uptake time has a greater effect on mediastinal than liver SUVlbm mean.
© 2012 The Authors. Journal of Medical Imaging and Radiation Oncology © 2012 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23551774     DOI: 10.1111/1754-9485.12015

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  14 in total

1.  Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685.

Authors:  Val J Lowe; Fenghai Duan; Rathan M Subramaniam; JoRean D Sicks; Justin Romanoff; Twyla Bartel; Jian Q Michael Yu; Brian Nussenbaum; Jeremy Richmon; Charles D Arnold; David Cognetti; Brendan C Stack
Journal:  J Clin Oncol       Date:  2019-02-15       Impact factor: 44.544

2.  Effects of Fever on 18F-FDG Distribution In Vivo: a Preliminary Study.

Authors:  Yutang Yao; Junjun Cheng; Minggang Su; Xiaohong Ou
Journal:  Mol Imaging Biol       Date:  2020-08       Impact factor: 3.488

3.  Impacts of biological and procedural factors on semiquantification uptake value of liver in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging.

Authors:  Mohd Hafizi Mahmud; Abdul Jalil Nordin; Fathinul Fikri Ahmad Saad; Ahmad Zaid Fattah Azman
Journal:  Quant Imaging Med Surg       Date:  2015-10

4.  Two-time-point FDG PET/CT: liver SULmean repeatability.

Authors:  Abdel K Tahari; Vasavi Paidpally; Alin Chirindel; Richard L Wahl; Rathan M Subramaniam
Journal:  AJR Am J Roentgenol       Date:  2015-02       Impact factor: 3.959

5.  Intrapatient repeatability of background 18F-FDG uptake on PET/CT.

Authors:  Rang Wang; Qiuping Fan; Rong Tian; Minggang Su
Journal:  Quant Imaging Med Surg       Date:  2021-09

6.  Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor.

Authors:  Gerben J C Zwezerijnen; Jakoba J Eertink; Maria C Ferrández; Sanne E Wiegers; Coreline N Burggraaff; Pieternella J Lugtenburg; Martijn W Heymans; Henrica C W de Vet; Josée M Zijlstra; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-27       Impact factor: 10.057

7.  Liver standardized uptake value corrected for lean body mass at FDG PET/CT: effect of FDG uptake time.

Authors:  Alin Chirindel; Krishna C Alluri; Abdel K Tahari; Muhammad Chaudhry; Richard L Wahl; Martin A Lodge; Rathan M Subramaniam
Journal:  Clin Nucl Med       Date:  2015-01       Impact factor: 7.794

8.  Prospective evaluation of the clinical utility of 18-fluorodeoxyglucose PET CT scanning in patients with von hippel-lindau-associated pancreatic lesions.

Authors:  Samira M Sadowski; Allison B Weisbrod; Ryan Ellis; Dhaval Patel; Meghna Alimchandani; Martha Quezado; Corina Millo; David J Venzon; Naris Nilubol; W Marston Linehan; Electron Kebebew
Journal:  J Am Coll Surg       Date:  2014-01-18       Impact factor: 6.113

Review 9.  Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: A systematic review.

Authors:  Clarice Sprinz; Stephan Altmayer; Matheus Zanon; Guilherme Watte; Klaus Irion; Edson Marchiori; Bruno Hochhegger
Journal:  PLoS One       Date:  2018-02-27       Impact factor: 3.240

10.  Effects of blood glucose level on 18F fluorodeoxyglucose (18F-FDG) uptake for PET/CT in normal organs: an analysis on 5623 patients.

Authors:  Clarice Sprinz; Matheus Zanon; Stephan Altmayer; Guilherme Watte; Klaus Irion; Edson Marchiori; Bruno Hochhegger
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.